Schrodinger signs strategic collaboration, software agreement with Bristol Myers Squibb for Bunsen AI co-scientist deployment
Reuters2026/08/05 12:36- Schrödinger signed a strategic collaboration and software agreement with Bristol Myers Squibb to deploy its AI co-scientist Bunsen in BMS research.
- Deal expands BMS use of Schrödinger’s computational platform, aiming to speed molecule prioritization and drug discovery decisions.
- Collaboration includes development of new Bunsen functionality, integrating Schrödinger workflows with RetroSynth for AI-driven synthesis planning.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The Most Critical Date for the Bullish Cryptocurrency Bill Clarity Act Has Been Set
BPPB posts 1H 2026 net profit of EUR 23.7 million
Valued at 2 trillion! Anthropic may become the largest IPO in history, roadshow starts in October, listing before the midterm elections in November
According to sources familiar with the matter, Anthropic is expected to begin its IPO roadshow as early as mid-October and complete its listing just a few days before the U.S. midterm elections in November.
Top Investor Says XRP Is A Global Agenda. Here’s why
Crypto prices
More
